Search Results - "Reese, Jens P"

Refine Results
  1. 1
  2. 2

    Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study by Winter, Yaroslav, von Campenhausen, Sonja, Gasser, Julia, Seppi, Klaus, Reese, Jens-P., Pfeiffer, Karl-P., Bötzel, Kai, Oertel, Wolfgang H., Dodel, Richard, Poewe, Werner

    Published in Journal of neurology (01-04-2010)
    “…Parkinson’s disease (PD) is associated with a reduction of health-related quality of life (HrQoL). Demographic and clinical determinants of HrQoL in PD have…”
    Get full text
    Journal Article
  3. 3

    Costs of Parkinson's disease in Eastern Europe: A Czech cohort study by Winter, Yaroslav, von Campenhausen, Sonja, Brozova, Hana, Skoupa, Jana, Reese, Jens P, Bötzel, Kai, Eggert, Karla, Oertel, Wolfgang H, Dodel, Richard, Ruzicka, Evzen

    Published in Parkinsonism & related disorders (01-01-2010)
    “…Abstract Life expectancy is increasing worldwide and the burden of Parkinson's disease (PD) is growing. There are several cost-of-illness studies for PD from…”
    Get full text
    Journal Article
  4. 4

    Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown by Schrader, Jörg, Deuster, Oliver, Rinn, Birgit, Schulz, Martina, Kautz, Andreas, Dodel, Richard, Meyer, Bernhard, Al-Abed, Yousef, Balakrishnan, Karthikeyan, Reese, Jens P, Bacher, Michael

    Published in BMC cancer (28-12-2009)
    “…Studies of the role of the cytokine macrophage-migration-inhibitory-factor (MIF) in malignant tumors have revealed its stimulating influence on cell-cycle…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam by Strzelczyk, Adam, Schubert-Bast, Susanne, Reese, Jens P, Rosenow, Felix, Stephani, Ulrich, Boor, Rainer

    Published in Epilepsy & behavior (01-05-2014)
    “…Abstract Dravet syndrome (DS) is a rare, severe childhood epilepsy syndrome that imposes a substantial burden on patients and their caregivers. This study…”
    Get full text
    Journal Article
  8. 8

    Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study by Winter, Yaroslav, Bezdolnyy, Yury, Katunina, Elena, Avakjan, Gagik, Reese, Jens P., Klotsche, Jens, Oertel, Wolfgang H., Dodel, Richard, Gusev, Eugene

    Published in Movement disorders (15-02-2010)
    “…Data on the incidence of Parkinson's disease (PD) and atypical parkinsonian syndromes (APS) in East European countries and Asia are limited. The objective of…”
    Get full text
    Journal Article
  9. 9

    Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany by Strzelczyk, Adam, Haag, Anja, Reese, Jens P, Nickolay, Tanja, Oertel, Wolfgang H, Dodel, Richard, Knake, Susanne, Rosenow, Felix, Hamer, Hajo M

    Published in Epilepsy & behavior (01-06-2013)
    “…Abstract This study evaluated trends in the resource use of patients with active epilepsy over a 5-year period at an outpatient clinic of a German epilepsy…”
    Get full text
    Journal Article
  10. 10

    Evaluation of health-care utilization among adult patients with epilepsy in Germany by Strzelczyk, Adam, Nickolay, Tanja, Bauer, Sebastian, Haag, Anja, Knake, Susanne, Oertel, Wolfgang H, Reif, Philipp S, Rosenow, Felix, Reese, Jens P, Dodel, Richard, Hamer, Hajo M

    Published in Epilepsy & behavior (01-04-2012)
    “…Abstract This study evaluated the resource use of patients with epilepsy in the German district of Marburg-Biedenkopf. A cross-sectional cohort of consecutive…”
    Get full text
    Journal Article
  11. 11

    Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease by Dams, Judith, Klotsche, Jens, Bornschein, Bernhard, Reese, Jens P, Balzer-Geldsetzer, Monika, Winter, Yaroslav, Schrag, Anette, Siderowf, Andrew, Oertel, Wolfgang H, Deuschl, Günther, Siebert, Uwe, Dodel, Richard

    Published in Health and quality of life outcomes (08-03-2013)
    “…Clinical studies employ the Unified Parkinson's Disease Rating Scale (UPDRS) to measure the severity of Parkinson's disease. Evaluations often fail to consider…”
    Get full text
    Journal Article
  12. 12

    Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease by Reese, Jens P, Dams, Judith, Winter, Yaroslav, Balzer-Geldsetzer, Monika, Oertel, Wolfgang H, Dodel, Richard

    Published in Expert opinion on pharmacotherapy (01-05-2012)
    “…Parkinson's disease (PD) is one of the most common neurodegenerative diseases. In the later (advanced) stages of PD, the initial treatment of early PD becomes…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Costs of Illness in a Russian Cohort of Patients with Parkinson’s Disease by Winter, Yaroslav, von Campenhausen, Sonja, Popov, Georgy, Reese, Jens P., Klotsche, Jens, Bötzel, Kai, Gusev, Eugene, Oertel, Wolfgang H., Dodel, Richard, Guekht, Alla

    Published in PharmacoEconomics (01-01-2009)
    “…Background: The economic burden associated with Parkinson’s disease (PD) is increasing as the worldwide population ages. While cost-of-illness studies for PD…”
    Get full text
    Journal Article
  15. 15

    Cost Effectiveness of Pharmacotherapies in Early Parkinson’s Disease by Eggert, Karla M., Reese, Jens P., Oertel, Wolfgang H., Dodel, Richard

    Published in CNS drugs (01-01-2008)
    “…Parkinson’s disease is one of the most common chronic neurodegenerative diseases. The progression of disease and the psychosocial consequences exert a major…”
    Get full text
    Journal Article
  16. 16

    Costs of Parkinson's disease and antiparkinsonian pharmacotherapy: an Italian cohort study by Winter, Yaroslav, von Campenhausen, Sonja, Reese, Jens P, Balzer-Geldsetzer, Monika, Longo, Katia, Spiga, Giuseppe, Boetzel, Kai, Eggert, Karla, Oertel, Wolfgang H, Dodel, Richard, Barone, Paolo

    Published in Neuro-degenerative diseases (01-01-2010)
    “…Antiparkinsonian pharmacotherapy is costly and the determinants of drug costs in Parkinson's disease (PD) have been poorly investigated. The objective of this…”
    Get more information
    Journal Article
  17. 17

    Cost of illness and health service patterns in Morbus Parkinson in Austria by von Campenhausen, Sonja, Winter, Yaroslav, Gasser, Julia, Seppi, Klaus, Reese, Jens-P, Pfeiffer, Karl-P, Geiger-Gritsch, Sabine, Bötzel, Kai, Siebert, Uwe, Oertel, Wolfgang H, Dodel, Richard, Poewe, Werner

    Published in Wiener Klinische Wochenschrift (2009)
    “…The objective of this study was to analyse the costs and the situation of care in patients with idiopathic Parkinson's disease (PD) in Austria. Continuously…”
    Get full text
    Journal Article
  18. 18

    Real-life evaluations of compliance with mandatory drug safety monitoring exemplified with tolcapone in Parkinson's disease by Unger, Marcus M, Reese, Jens P, Oertel, Wolfgang H, Eggert, Karla M

    Published in European neurology (01-01-2008)
    “…In 1998, the European Medicines Agency suspended the approval for tolcapone in Parkinson's disease (PD) with motor complications due to the drug's implication…”
    Get more information
    Journal Article
  19. 19

    Krankheitskosten und Versorgungssituation bei Morbus Parkinson – eine Analyse in Österreich by von Campenhausen, Sonja, Winter, Yaroslav, Gasser, Julia, Seppi, Klaus, Reese, Jens-P., Pfeiffer, Karl-P., Geiger-Gritsch, Sabine, Bötzel, Kai, Siebert, Uwe, Oertel, Wolfgang H., Dodel, Richard, Poewe, Werner

    Published in Wiener Klinische Wochenschrift (01-09-2009)
    “…Zusammenfassung ZIELSETZUNG: Ziel dieser Studie war die Ermittlung der Krankheitskosten und der Versorgungssituation bei Patienten mit Parkinson-Erkrankung in…”
    Get full text
    Journal Article
  20. 20

    Preference-based Health status in a German outpatient cohort with multiple sclerosis by Reese, Jens Peter, Wienemann, Gabriele, John, Axel, Linnemann, Alexandra, Balzer-Geldsetzer, Monika, Mueller, Ulrich Otto, Eienbröker, Christian, Tackenberg, Björn, Dodel, Richard

    Published in Health and quality of life outcomes (03-10-2013)
    “…To prospectively determine health status and health utility and its predictors in patients with multiple sclerosis (MS). A total of 144 MS patients (mean age:…”
    Get full text
    Journal Article